Statement.io Enhances Leadership Team to Drive AI Innovation and Future Growth

Strategic Hires Reinforce Commitment to Transforming Financial Management With Cutting-Edge AI Solutions and Commercial Excellence

NEW YORK, (FreePR.org) -- Statement.io, the AI-driven platform revolutionizing treasury and cash management, is pleased to announce two key additions to its executive leadership team. Richard Serpa has been appointed as Vice President of Sales, and Corinna Krueger will serve as Vice President of Marketing. These appointments signal Statement.io's commitment to advancing financial management solutions through cutting-edge AI and accelerating the company’s growth trajectory.

Strategic Leadership to Propel Growth

Richard Serpa brings over two decades of experience in driving growth for SaaS and enterprise technology companies. During his 13-year tenure at Kyriba, a global leader in enterprise liquidity management, Serpa played a pivotal role in building high-performing sales teams, launching new business lines, and expanding market coverage across North America. His expertise in navigating competitive markets and implementing revenue-driven strategies will support Statement.io’s rapid expansion.

Corinna Krueger joins with more than 15 years of marketing leadership experience in scaling B2B SaaS organizations. A full-stack marketer, Krueger has a proven track record of driving growth through go-to-market strategies, brand development, demand generation, and product marketing. Her contributions will be instrumental in enhancing Statement.io’s market presence and executing strategic initiatives to accelerate long-term success.

Leadership to Advance Innovation

“The addition of Richard and Corinna to our team marks an important milestone for Statement.io as we continue to scale our operations and innovate for the future,” said Idan Vlodinger, CEO and co-founder of Statement.io. “Their deep expertise in scaling organizations and driving results will enable us to strengthen our go-to-market strategies, deepen customer relationships, and deliver groundbreaking AI-native solutions for treasury and financial management."

Positioned for Future Success

With these leadership enhancements, Statement.io is poised to elevate its market position, drive customer engagement, and continue delivering transformative solutions that empower CFOs and finance teams to optimize liquidity, manage risk, and achieve strategic growth.

About Statement.io

Statement.io is an AI-native platform reimagining financial operations for global businesses. Integrating seamlessly with banks, ERPs, PSPs, and other financial systems, Statement.io uses advanced AI and machine learning to enrich financial data, automate workflows, and provide real-time insights into cash positions, cash flow forecasting, and transaction categorization. The platform’s AI-driven insights help businesses optimize working capital, enhance liquidity performance, and streamline treasury operations without relying on IT resources. Statement.io is supported by prominent investors, including Glilot Capital Partners, Mensch Capital Partners, and Titan Capital.

For more information, visit Statement.io.

###

Sponsor Message

Canadian pharmacies help Americans save on critical prescriptions like Lipitor, Crestor, and Nexium. For those managing chronic conditions, insulin like Humalog and Lantus is crucial for diabetes, while respiratory treatments like Advair Diskus and Ventolin inhalers address asthma and COPD. Mental health treatments like Zoloft, Prozac, and Abilify offer essential support for individuals coping with depression, anxiety, or bipolar disorder, while medications such as Eliquis, Plavix, and Xarelto play a vital role in stroke prevention and heart health. Pain treatments like Celebrex and thyroid medications like Synthroid remain top choices among frequent orders. Furthermore, popular medications like Viagra and Cialis provide relief for erectile dysfunction, while Januvia helps regulate diabetes. For those impacted by narcolepsy or excessive daytime sleepiness, Provigil and Nuvigil are indispensable. Patients across the U.S. can access affordable medications like Cymbalta for nerve pain and Aricept for Alzheimer's through Canadian pharmacies.